Genmab | GEN - Loan Capital


Genmab reported DKK5.14B in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Agios Pharmaceuticals USD 1.06M 0 Sep/2022
Almirall EUR 303.77M 21.04M Jun/2026
Amgen USD 51.86B 27M Jun/2026
argenx SE USD 36M 432K Jun/2026
AstraZeneca USD 26.01B 46M Jun/2026
Bayer EUR 30.68B 1.15B Mar/2026
BioMarin Pharmaceutical USD 1.43B 833.11M Mar/2026
Demant DKK 18.98B 3.71B Dec/2025
Fresenius Medical Care EUR 5.74B 895.27M Mar/2026
Genmab DKK 5.14B 5.01B Dec/2025
GlaxoSmithKline GBP 13.95B 65M Jun/2026
GN Store Nord DKK 8.1B 790M Mar/2026
GRIFOLS EUR 7.17B 1.91B Jun/2026
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Insmed USD 543.51M 1.3M Jun/2026
Lakefront Biotherapeutics EUR 4.85M 335K Mar/2026
Lonza CHF 3.88B 323M Dec/2025
Merck EUR 10.8B 72M Mar/2026
Novartis USD 37.49B 42M Jun/2026
Regeneron Pharmaceuticals USD 1.99B 400K Jun/2026
Roche Holding CHF 25.22B 2.21B Jun/2026
Sanofi EUR 14.65B 806M Jun/2026
UCB EUR 2.18B 634M Dec/2025